Millendo Therapeutics
Endocrine Diseases

Millendo develops novel, disease-modifying treatments for specialty and orphan endocrine diseases caused by hormone dysregulation. It was founded in 2012 as a spin-out from the University of Michigan and is based in Ann Arbor, Michigan. NASDAQ: MLND

 


University
University of Michigan
Sector
Life Science
Status
Public
Initial Investment Stage
Early
View Website